Changes in Hong Kong stocks | Jietai Technology-P (07666) increased by more than 8% after performance, half-year revenue surpassed 47% of last year's full year, and accelerated the achievement of the company's commercialization milestone

The Zhitong Finance App learned that Jitai Technology-P (07666) rose more than 8% after the results. As of press release, it had risen 7.97% to HK$14.9, with a turnover of HK$16.821 million.

According to the news, on August 25, Jietai Technology revealed its 2026 interim results. During the reporting period, the company's revenue reached 154 million yuan, a sharp increase of 13339% over the previous year, exceeding 47% of last year's annual revenue. At the same time, the company's financial structure continued to be optimized: the company's current R&D expenditure increased 48.1% year-on-year to 172 million yuan; adjusted net loss narrowed sharply by 56.4% to 51.1 million yuan; current cash reserves were 3,025 billion yuan, and the balance ratio was optimized to 9% from 19.3% at the end of 2025. As the commercialization results of NanoForge enter a period of centralized release, it is expected that Jietai's core innovation value will continue to be double verified by the global industry and capital markets.

In the first half of 2026, NanoForge's platform capabilities were substantially recognized by international professional investment institutions and leading multinational pharmaceutical companies, and continuously achieved commercial milestones, once again verifying NanoForge's ability to continuously produce innovative assets with global value. It is worth mentioning that recently, the world's first clinically proven mRNA therapeutic cancer vaccine confirmed the viability and commercialization value of mRNA technology for cancer treatment. In this context, the NanoForge platform's ability to develop mRNA cancer vaccines and LNP delivery capabilities have been recognized by the secondary market, driving the company's stock price to a maximum increase of more than 35% in a single day.